Cargando…

Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer

BACKGROUND: Patient reported outcomes (PROs) have been associated with improved symptom management and quality of life in patients with cancer. However, the implementation of PROs in an academic clinical practice has not been thoroughly described. Here we report on the execution, feasibility and hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Generalova, Olga, Roy, Mohana, Hall, Evan, Shah, Sumit A., Cunanan, Kristen, Fardeen, Touran, Velazquez, Brianna, Chu, Gilbert, Bruzzone, Bianca, Cabot, Anna, Fisher, George A., Srinivas, Sandy, Fan, Alice C., Haraldsdottir, Sigurdis, Wakelee, Heather A., Neal, Joel W., Padda, Sukhmani K., Johnson, Tyler, Heestand, Gregory M., Hsieh, Robert W., Ramchandran, Kavitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443731/ https://www.ncbi.nlm.nih.gov/pubmed/34524558 http://dx.doi.org/10.1186/s41687-021-00358-2

Ejemplares similares

Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors
por: Waliany, Sarah, et al.
Publicado: (2021)

Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors
por: Singhal, Surbhi, et al.
Publicado: (2022)

Mobile eHealth solution (ePRO)
por: Saganowski, Stanisław, et al.
Publicado: (2015)

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging
por: Alhusaini, Saud, et al.
Publicado: (2023)

Advances in systemic therapy for advanced pancreatobiliary malignancies
por: Halfdanarson, Thorvardur R, et al.
Publicado: (2013)

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer
por: Padda, Sukhmani K., et al.
Publicado: (2021)

An amino-terminal BRAF deletion accounting for acquired resistance to RAF/EGFR inhibition in colorectal cancer
por: Tung, Jack K., et al.
Publicado: (2020)

Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing
por: Vlessis, Katherine, et al.
Publicado: (2019)

What ePROs are telling us about patients with substance use disorder
por: Krasteva, S., et al.
Publicado: (2022)

Electronic patient-reported outcome (ePRO) application for patients with prostate cancer
por: Mohseni, Majid, et al.
Publicado: (2023)

Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type
por: Padda, Sukhmani K., et al.
Publicado: (2021)

Navigating the Landscape of Molecular Testing and Targeted Treatment of Non–Small Cell Lung Cancer
por: Padda, Sukhmani K., et al.
Publicado: (2016)

A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors
por: Padda, Sukhmani K., et al.
Publicado: (2011)

A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs
por: Shen, Biyu, et al.
Publicado: (2022)

Key methodological considerations for usability testing of electronic patient-reported outcome (ePRO) systems
por: Aiyegbusi, Olalekan Lee
Publicado: (2019)

The role of induction therapy for thymic malignancies: a narrative review
por: Patel, Deven C., et al.
Publicado: (2020)

ePro-ClearSee: a simple immunohistochemical method that does not require sectioning of plant samples
por: Nagaki, Kiyotaka, et al.
Publicado: (2017)

Content validity and ePRO usability of the BPI-sf and “worst pain” item with pleural and peritoneal mesothelioma
por: Gelhorn, Heather L., et al.
Publicado: (2018)

ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study
por: Iivanainen, Sanna, et al.
Publicado: (2019)

AquaScouts: ePROs Implemented as a Serious Game for Children With Cancer to Support Palliative Care
por: Hoffmann, Stefan, et al.
Publicado: (2021)

Patient-reported distress at a cancer center during the COVID-19 pandemic
por: Shah, Manan P., et al.
Publicado: (2023)

Dietary Exposures and Interventions in Inflammatory Bowel Disease: Current Evidence and Emerging Concepts
por: Gubatan, John, et al.
Publicado: (2023)

Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable Discussion
por: Das, Millie, et al.
Publicado: (2021)

eProS—a database and toolbox for investigating protein sequence–structure–function relationships through energy profiles
por: Heinke, Florian, et al.
Publicado: (2013)

Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment
por: Charville, Gregory W., et al.
Publicado: (2018)

Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials
por: Coons, Stephen Joel, et al.
Publicado: (2014)

Patient Perspective in the Development of Electronic Patient-Reported Outcomes (ePROs) in Seizure Disorders: A Patient-Centric Approach
por: Khan, Anzalee, et al.
Publicado: (2020)

Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
por: Hayashida, Tetsu, et al.
Publicado: (2022)

Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment
por: Hofer, Silvia, et al.
Publicado: (2023)

Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis
por: Seppen, Bart F., et al.
Publicado: (2023)

Radiological tumor classification across imaging modality and histology
por: Wu, Jia, et al.
Publicado: (2021)

Erratum to: Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials
por: Coons, Stephen Joel, et al.
Publicado: (2015)

Psychometric validation and testing of the 10-item pediatric daily chest-related electronic patient reported outcome (ePRO) diary
por: Arbuckle, Rob, et al.
Publicado: (2023)

Electronic patient-reported outcomes in clinical kidney practice (ePRO Kidney): a process evaluation of educational support for clinicians
por: Schick-Makaroff, Kara, et al.
Publicado: (2023)

Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford
por: Abrha, Aser, et al.
Publicado: (2020)

The provider perspective: investigating the effect of the Electronic Patient-Reported Outcome (ePRO) mobile application and portal on primary care provider workflow
por: Hans, Parminder K., et al.
Publicado: (2017)

Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot study
por: von Rohr, Sophie, et al.
Publicado: (2023)

The role of palliative care in the management of patients with lung cancer
por: Tan, Irena, et al.
Publicado: (2020)

Clinical efficacy, safety, and subjective experience based on ePRO in HIV‐infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China
por: Kong, Linghong, et al.
Publicado: (2023)

A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
por: Roy, Mohana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f12er2r52jgciuh2kns4bqgp9r